Talis Q2 Earnings Snapshot
Slightly above 67% of Talis Biomedical's investor base is looking to short. The analysis of overall sentiment of trading Talis Biomedical Corp pink sheet suggests that many investors are alarmed at this time. Talis Biomedical's investing sentiment can be driven by a variety of factors including economic data, Talis Biomedical's earnings reports, geopolitical events, and overall market trends.
Talis Biomedical pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Talis daily returns and investor perception about the current price of Talis Biomedical Corp as well as its diversification or hedging effects on your existing portfolios.
Talis |
CHICAGO Talis Biomedical Corp. TLIS on Monday reported a loss of 8.8 million in its second quarter. The Chicago-based company said it had a loss of 4.86 per share.
Read at finance.yahoo.com
![]() |
Talis Biomedical Fundamental Analysis
We analyze Talis Biomedical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Talis Biomedical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Talis Biomedical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Debt
Total Debt Comparative Analysis
Talis Biomedical is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Talis Biomedical Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Talis Biomedical pink sheet to make a market-neutral strategy. Peer analysis of Talis Biomedical could also be used in its relative valuation, which is a method of valuing Talis Biomedical by comparing valuation metrics with similar companies.
Peers
Talis Biomedical Related Equities
BJDX | Bluejay Diagnostics | 10.59 | ||||
BVS | Bioventus | 4.21 | ||||
NPCE | Neuropace | 3.11 | ||||
NUWE | Nuwellis | 2.46 | ||||
SGHT | Sight Sciences | 0.38 | ||||
HSCS | Heart Test | 0.84 | ||||
SSKN | STRATA Skin | 1.12 | ||||
TNON | Tenon Medical | 3.60 | ||||
BBLG | Bone Biologics | 5.32 | ||||
TIVC | Tivic Health | 10.00 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Talis Pink Sheet
If you are still planning to invest in Talis Biomedical Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Talis Biomedical's history and understand the potential risks before investing.
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |